Literature DB >> 15134424

Women and bipolar disorder across the life span.

Dorothy Sit1.   

Abstract

Bipolar I disorder occurs in approximately 1% of the adult population, and it affects women and men equally. Women develop bipolar II disorder, bipolar depression, mixed mania, and a rapid-cycling course of illness more commonly than men and are at greater risk of such comorbid conditions as alcohol use problems, thyroid disease, medication-induced obesity, and migraine headaches. The treatment of bipolar disorder remains challenging. Although lithium reduces symptoms and prevents recurrence with good efficacy, a significant number of patients stop taking it. Furthermore, several anticonvulsants and antidepressants are prescribed off label for acute episodes and prophylaxis despite the lack of adequate research support. Psychotherapy may alleviate mania or depression and improve treatment compliance, yet its ability to prevent relapse remains uncertain. Changes throughout the reproductive cycle also have an impact on the onset and presentation of bipolar symptoms and the choice of treatment. This article provides an overview of common presentations and comorbidities, along with approaches to evaluation and treatment of women with bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134424      PMCID: PMC3107596     

Source DB:  PubMed          Journal:  J Am Med Womens Assoc (1972)        ISSN: 0098-8421


  125 in total

1.  Age onset of psychotic versus non-psychotic bipolar illness in men and in women.

Authors:  Aysegul Yildiz; Gary S Sachs
Journal:  J Affect Disord       Date:  2003-04       Impact factor: 4.839

2.  A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year.

Authors:  Dominic H Lam; Edward R Watkins; Peter Hayward; Jenifer Bright; Kim Wright; Natalie Kerr; Gina Parr-Davis; Pak Sham
Journal:  Arch Gen Psychiatry       Date:  2003-02

3.  A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.

Authors:  Charles L Bowden; Joseph R Calabrese; Gary Sachs; Lakshmi N Yatham; Shaheen Akthar Asghar; Magne Hompland; Paul Montgomery; Nancy Earl; Tonya M Smoot; Joseph DeVeaugh-Geiss
Journal:  Arch Gen Psychiatry       Date:  2003-04

4.  Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.

Authors:  Bernard L Harlow; Lauren A Wise; Michael W Otto; Claudio N Soares; Lee S Cohen
Journal:  Arch Gen Psychiatry       Date:  2003-01

5.  Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

Authors:  William T Regenold; Ramesh K Thapar; Christopher Marano; Sridevi Gavirneni; Prasad V Kondapavuluru
Journal:  J Affect Disord       Date:  2002-06       Impact factor: 4.839

Review 6.  Carbamazepine and valproate in the maintenance treatment of bipolar disorder.

Authors:  Paul E Keck; Susan L McElroy
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

7.  Valproate, bipolar disorder and polycystic ovarian syndrome.

Authors:  Roger S McIntyre; Deborah A Mancini; Sonia McCann; Janaki Srinivasan; Sidney H Kennedy
Journal:  Bipolar Disord       Date:  2003-02       Impact factor: 6.744

8.  Menstrual cycle related mood changes in women with bipolar disorder.

Authors:  Natalie Rasgon; Michael Bauer; Tasha Glenn; Shana Elman; Peter C Whybrow
Journal:  Bipolar Disord       Date:  2003-02       Impact factor: 6.744

Review 9.  A review of the effect of atypical antipsychotics on weight.

Authors:  H Nasrallah
Journal:  Psychoneuroendocrinology       Date:  2003-01       Impact factor: 4.905

10.  The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases.

Authors:  Lewis L Judd; Hagop S Akiskal
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

View more
  10 in total

1.  Disruption of Glutamate Homeostasis in the Brain of Rat Offspring Induced by Prenatal and Early Postnatal Exposure to Maternal High-Sugar Diet.

Authors:  Jozef Mizera; Bartosz Pomierny; Anna Sadakierska-Chudy; Beata Bystrowska; Lucyna Pomierny-Chamiolo
Journal:  Nutrients       Date:  2022-05-24       Impact factor: 6.706

Review 2.  Weighing the Risks: the Management of Bipolar Disorder During Pregnancy.

Authors:  Michael Thomson; Verinder Sharma
Journal:  Curr Psychiatry Rep       Date:  2018-03-17       Impact factor: 5.285

Review 3.  [Specific aspects of treatment for women with bipolar affliction].

Authors:  J Sasse; M Pilhatsch; A Forsthoff; H Grunze; J Neutze; A Pfennig; B Schmitz; A Schwenkhagen; M Bauer
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

4.  Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.

Authors:  Eydie L Moses-Kolko; Katherine L Wisner; Julie C Price; Sarah L Berga; Wayne C Drevets; Barbara H Hanusa; Tammy L Loucks; Carolyn C Meltzer
Journal:  Fertil Steril       Date:  2007-06-04       Impact factor: 7.329

Review 5.  Sex is a defining feature of neuroimaging phenotypes in major brain disorders.

Authors:  Lauren E Salminen; Meral A Tubi; Joanna Bright; Sophia I Thomopoulos; Alyssa Wieand; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2021-05-05       Impact factor: 5.038

6.  Bipolar in Women: Any Gender-based Difference?

Authors:  Ahmed Naguy
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

7.  Evaluation of Bipolar Disorder in Several Relapses over Time Using Generalized Estimating Equations.

Authors:  Payam Amini; Roya Najafi-Vosough; Ali Ghaleiha; Hossein Mahjub
Journal:  Iran J Psychiatry       Date:  2017-07

8.  Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study.

Authors:  Amanda U Sibanyoni; Marinda Joubert; Kalaivani Naidu
Journal:  S Afr J Psychiatr       Date:  2022-01-31       Impact factor: 1.550

Review 9.  Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications.

Authors:  Amber N Edinoff; Nancy S Silverblatt; Hayley E Vervaeke; Cassidy C Horton; Eden Girma; Alan D Kaye; Adam Kaye; Jessica S Kaye; Andrew J Garcia; Elisa E Neuchat; Treniece N Eubanks; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16

10.  Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus.

Authors:  Amy V Jones; James R F Hockley; Craig Hyde; Donal Gorman; Ana Sredic-Rhodes; James Bilsland; Gordon McMurray; Nicholas A Furlotte; Youna Hu; David A Hinds; Peter J Cox; Serena Scollen
Journal:  Pain       Date:  2016-11       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.